Henry F. Blissenbach

Henry F. Blissenbach

Plus aucun poste en cours

82 ans
Distribution Services
Health Technology
Health Services

Profil

Henry F.
Blissenbach
, serves as a Director, President and Chief Executive Officer for BioScrip Inc. Dr. Blissenbach was named to this position upon the consummation of the merger between MIM Corporation and Chronimed, Inc. effective March 2005.
Dr. Blissenbach previously served as Chairman and Chief Executive Officer of Chronimed, Inc. He was appointed Chairman of the Board of Directors and Chief Executive Officer of Chronimed on July 1, 2000.
Dr. Blissenbach was named President and Chief Operating Officer of Chronimed in May 1997.
He became a director of Chronimed in September 1995.
From 1992 to 1997, he served as President of Diversified Pharmaceutical Services, Inc., a UnitedHealthcare subsidiary until 1994 and afterwards a subsidiary of SmithKline Beecham Corp.
Diversified Pharmaceutical Services, Inc. was a pharmacy benefit management firm.
Dr. Blissenbach also serves as a director of Ligand Pharmaceuticals Inc., a publicly held biopharmaceutical development company, and Opportunity Partners, Inc., a nonprofit company.

Anciens postes connus de Henry F. Blissenbach

SociétésPosteFin
Président 09/08/2004
President -
LIGAND PHARMACEUTICALS INCORPORATED Directeur/Membre du Conseil -
Voir l'expérience en détail de Henry F. Blissenbach

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Henry F. Blissenbach

Sociétés liées

Sociétés cotées1
LIGAND PHARMACEUTICALS INCORPORATED

Health Technology

Entreprise privées2

Distribution Services

Health Services

  1. Bourse
  2. Insiders
  3. Henry F. Blissenbach